---
title: "China Health Technology Fully Subscribes Rights Issue to Fund Ginseng and Aesthetics Expansion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297091368.md"
description: "China Health Technology Group completed a fully subscribed rights issue, raising approximately HK$51.5 million. While only 28.62% of shares were taken up by existing shareholders, the remaining 71.38% were placed with independent investors at HK$0.25 per share. The net proceeds will be allocated to expand its ginseng plantation business (HK$22 million), invest in medical aesthetics infrastructure (HK$18 million), and support working capital (HK$10 million)."
datetime: "2026-08-26T15:08:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297091368.md)
  - [en](https://longbridge.com/en/news/297091368.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297091368.md)
generator: "portal-rs"
---

# China Health Technology Fully Subscribes Rights Issue to Fund Ginseng and Aesthetics Expansion

China Bozza Development Holdings Limited ( (HK:1069) ) has shared an announcement.

China Health Technology Group completed a rights issue on the basis of two rights shares for every existing share and a concurrent placing, resulting in full subscription of 205,848,440 new shares. Only about 28.62% of the rights shares were taken up by existing shareholders, while the remaining 71.38% were successfully placed with at least six independent investors at HK$0.25 per share, raising gross proceeds of approximately HK$51.5 million.

The company plans to deploy around HK$22 million of the net HK$50 million raised to expand its ginseng plantation business, including acquiring forests and new plantation sites and funding marketing activities. About HK$18 million will be invested in the medical aesthetics industry for equipment and facility build-out, while roughly HK$10 million is earmarked for general working capital, indicating a strategic push into higher-margin health segments and operational strengthening.

**More about China Bozza Development Holdings Limited**

China Health Technology Group Holding Company Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates in the health-related sector with a growing focus on ginseng cultivation and medical aesthetics. The group is expanding its agricultural footprint through ginseng plantations and is also investing in medical aesthetic services and infrastructure to broaden its healthcare offerings.

**Average Trading Volume:** 1,399,951

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$86.46M

### Related Stocks

- [01069.HK](https://longbridge.com/en/quote/01069.HK.md)

## Related News & Research

- [Lenovo Group (LNVGF): New Buy Recommendation for This Technology Giant](https://longbridge.com/en/news/306391832.md)
- [South Korea prepares market stabilisation funds after KOSPI hits 10-month low](https://longbridge.com/en/news/306391779.md)
- [Höegh Autoliners ASA Just Missed EPS By 9.5%: Here's What Analysts Think Will Happen Next](https://longbridge.com/en/news/306385955.md)
- [Nio Firefly debuts Haven special edition in Oslo, plans spring 2027 launch in Europe](https://longbridge.com/en/news/306380548.md)
- [Results: NKT A/S Exceeded Expectations And The Consensus Has Updated Its Estimates](https://longbridge.com/en/news/306385316.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**